Small High-Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL-Associated Phospholipase A2 in Subjects with Prediabetes
出版年份 2013 全文链接
标题
Small High-Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL-Associated Phospholipase A2 in Subjects with Prediabetes
作者
关键词
Prediabetes, Impaired fasting glucose, HDL subclasses, Lipoprotein-associated phospholipase A<sub>2</sub>, LDL subclasses, Paraoxonase, Apolipoprotein C-II, Apolipoprotein C-III
出版物
LIPIDS
Volume 48, Issue 6, Pages 547-555
出版商
Wiley
发表日期
2013-04-01
DOI
10.1007/s11745-013-3787-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men
- (2013) J. Wang et al. JOURNAL OF INTERNAL MEDICINE
- Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study
- (2013) TD Filippatos et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes
- (2012) R.I. Coniglio et al. CLINICAL BIOCHEMISTRY
- High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
- (2012) Li Tian et al. Lipids in Health and Disease
- A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease
- (2012) Anastazia A. Kei et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
- (2012) Aneta Otocka-Kmiecik et al. PROGRESS IN LIPID RESEARCH
- Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
- (2011) C. Morgantini et al. DIABETES
- Standards of Medical Care in Diabetes--2012
- (2011) DIABETES CARE
- Prediabetes: To treat or not to treat?
- (2011) Elisavet Moutzouri et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The complexity of HDL
- (2010) Gordon A. Francis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dysfunctional High-Density Lipoprotein and Atherosclerosis
- (2010) Shawn Ragbir et al. Current Atherosclerosis Reports
- High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
- (2010) Christian Besler et al. CURRENT PHARMACEUTICAL DESIGN
- The Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients
- (2010) E. S. Nakou et al. LIPIDS
- Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
- (2009) Constantinos C. Tellis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia
- (2009) Michael S. Kostapanos et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia
- (2008) E. S. Nakou et al. CURRENT MEDICAL RESEARCH AND OPINION
- Economic Costs of Diabetes in the U.S. in 2007
- (2008) DIABETES CARE
- The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
- (2008) ES Nakou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome
- (2008) Theodosios D. Filippatos et al. Journal of Clinical Lipidology
- Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile
- (2008) G Dell'Omo et al. JOURNAL OF HUMAN HYPERTENSION
- Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome
- (2008) K. G. Lagos et al. LIPIDS
- The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome
- (2007) T. D. Filippatos et al. DIABETES OBESITY & METABOLISM
- Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women
- (2007) T. Tzotzas et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started